Work

An open-label, single-arm, multi-institutional phase II trial of avelumab for recurrent, metastatic nasopharyngeal carcinoma.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps6092

Authors: Assuntina Gesualda Sacco, Karen Messer, Rom S. Leidner, A. Dimitrios Colevas, Jorge J. Nieva, Nicole Grace Chau, Chaitali Singh Nangia, Benjamin Pinsky, Kathryn A. Gold, Gregory A. Daniels, Ezra E.W. Cohen

Institutions: Moores Cancer Center, Stanford Cancer Institute, University of Southern California, Dana-Farber Cancer Institute, University of California, Irvine, University of California, Irvine Medical Center, Stanford University, University of California San Diego

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890585656

Cites:

Cited by:

Related to: 10